10 completed. 10 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 10 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Bronchial Asthma: new trials by email Literature Review of Bronchial Asthma trials Research Report on Bronchial Asthma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma XC8 100 mg, Placebo - Bronchial Asthma, Eosinophilic Asthma | Phase 2 | Completed | Chemlmmune Therapeutics LLC | 70 | 2020-12-16 | 2021-09-22 |
| XC8 in the Treatment of Patients With Bronchial Asthma XC8 Oral Tablet, Placebo Oral Tablet - Bronchial Asthma | Phase 2 | Completed | PHARMENTERPRISES LLC | 120 | 2016-09-20 | 2018-03-01 |
| A Study to Assess Safety and Efficacy of a Novel Treatment, Keratinocyte Growth Factor (KGF), in Asthmatic Patients Keratinocyte Growth factor, Saline placebo - Bronchial Asthma | Phase 2 | Completed | University Hospital Southampton NHS Foundation Trust | 24 | 2009-08-01 | 2016-10-13 |
| Treatment of Bronchial Asthma With Borage and Echium Seed Oils Borage Seed Oil and Echium Seed Oil, Corn Oil - Bronchial Asthma | Phase 1 / Phase 2 | Completed | Brigham and Women's Hospital | 43 | 2008-12-01 | 2017-07-03 |
| Research on Traditional Chinese Medicine (TCM) Clinical Treatment of the Acute Episode of Bronchial Asthma. warming lung and relieving asthmatic granule and Securing origin and warming lung emplastrum, clearing lung and relieving asthmatic granule and securing origin and clearing lung emplastrum, securing origin and relieving asthmatic granule and securing origin and nourishing lung emplastrum - Bronchial Asthma | Phase 2 | Completed | Liaoning University of Traditional Chinese Medicine | 360 | 2008-12-01 | 2011-02-11 |
| A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma inhaled corticosteroid therapy - Bronchial Asthma | Phase 1 / Phase 2 | Completed | Novartis | 26 | 2006-07-01 | 2007-06-22 |
| OC000459 Bronchial Allergen Challenge OC000459, Placebo - Bronchial Asthma | Phase 2 | Completed | Oxagen Ltd | 20 | 2006-02-01 | 2010-01-26 |
| Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05). Roflumilast - Bronchial Asthma | Phase 2 / Phase 3 | Completed | AstraZeneca | 450 | 2004-05-01 | 2026-06-10 |
| Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma tacrolimus - Asthma, Bronchial, Bronchial Asthma | Phase 2 | Completed | Astellas Pharma Inc | 370 | 2008-04-17 | |
| Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma Tacrolimus - Asthma, Bronchial, Bronchial Asthma | Phase 2 | Completed | Astellas Pharma Inc | 160 | 2008-04-17 |
Asthma (10) · Respiratory Aspiration (2) · Inflammation (1) · Pulmonary Eosinophilia (1)
Bronchial Diseases (10) · Hypersensitivity (10) · Hypersensitivity, Immediate (10) · Immune System Diseases (10) · Lung Diseases (10) · Lung Diseases, Obstructive (10) · Respiratory Hypersensitivity (10) · Respiratory Tract Diseases (10) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Respiration Disorders (2) · Eosinophilia (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hypereosinophilic Syndrome (1)
Tacrolimus (2) · histamine glutarimide (2) · (5-fluoro-2-methyl-3-quinolin-2-ylmethylindo-1-yl)acetic acid (1) · Corn Oil (1) · Fibroblast Growth Factor 7 (1) · Roflumilast (1) · borage oil (1)
Astellas Pharma Inc (2) · AstraZeneca (1) · Brigham and Women's Hospital (1) · Chemlmmune Therapeutics LLC (1) · Liaoning University of Traditional Chinese Medicine (1) · Novartis (1) · Oxagen Ltd (1) · PHARMENTERPRISES LLC (1) · University Hospital Southampton NHS Foundation Trust (1)
Russia (4) · Germany (3) · Czechia (2) · Poland (2) · Ukraine (2) · United Kingdom (2) · Bulgaria (1) · Hungary (1) · Japan (1) · United States (1)
David Singh, MD (1) · Elliot Israel, MD (1) · Peter H Howarth, BSc, MBBS (1) · R.G.M.vom Amsterdam, MD (1)
PMID 22496329, PMID 25485197, PMID 33095411
P50AT002782 (1)